Long-Term Assets: The sum of all assets classified as non-current.
Oasmia Pharmaceutical AB (OASMY) had Long-Term Assets of $18.10M for the most recently reported fiscal quarter, ending 2023-09-30.
| Income Statement Financials | |
-- |
|
$-1.46M |
|
-- |
|
-- |
|
$1.53M |
|
$-1.53M |
|
$0.07M |
|
$-1.46M |
|
$-1.46M |
|
$-1.46M |
|
$-1.46M |
|
$-1.46M |
|
$-1.46M |
|
$-1.53M |
|
$-1.53M |
|
179.35M |
|
179.35M |
|
$-0.01 |
|
$-0.01 |
|
| Balance Sheet Financials | |
$8.12M |
|
$0.95M |
|
|
Long-Term Assets |
$18.10M |
$26.22M |
|
$1.75M |
|
$0.32M |
|
$0.32M |
|
$2.06M |
|
$24.16M |
|
$21.25M |
|
$24.16M |
|
179.35M |
|
| Cash Flow Statement Financials | |
$-5.41M |
|
$5.16M |
|
$-0.26M |
|
$0.88M |
|
$0.39M |
|
$-0.49M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.65 |
|
-- |
|
-- |
|
0.01 |
|
0.02 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-5.47M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-6.04% |
|
-6.87% |
|
-5.57% |
|
-5.97% |
|
$0.13 |
|
$-0.03 |
|
$-0.03 |
|